Technical Analysis for KRTX - Karuna Therapeutics, Inc.

Grade Last Price % Change Price Change
D 111.05 -1.39% -1.57
KRTX closed down 1.39 percent on Tuesday, April 13, 2021, on 49 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical KRTX trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish -1.39%
Down 3 Days in a Row Weakness -1.39%
20 DMA Resistance Bearish -5.01%
Fell Below 50 DMA Bearish -5.01%
MACD Bearish Signal Line Cross Bearish -5.01%
NR7 Range Contraction -5.01%
Fell Below 20 DMA Bearish -5.84%
50 DMA Support Bullish -5.84%
Multiple of Ten Bearish Other -5.84%
Multiple of Ten Bearish Other -7.41%
Older End-of-Day Signals for KRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 6 hours ago
Fell Below Lower Bollinger Band about 6 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
Lower Bollinger Band Support about 9 hours ago
Down 1% about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Karuna Therapeutics, Inc. Description

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Symptoms Schizophrenia Nervous System Disorders Central Nervous System Disorders Alzheimer's Treatment Of Central Nervous System Disorders Psychosis Kar Xt Puretech Health

Is KRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 146.97
52 Week Low 69.58
Average Volume 220,516
200-Day Moving Average 97.81
50-Day Moving Average 118.40
20-Day Moving Average 117.34
10-Day Moving Average 118.02
Average True Range 6.15
ADX 13.42
+DI 15.14
-DI 21.06
Chandelier Exit (Long, 3 ATRs ) 108.05
Chandelier Exit (Short, 3 ATRs ) 127.55
Upper Bollinger Band 124.48
Lower Bollinger Band 110.20
Percent B (%b) 0.06
BandWidth 12.17
MACD Line -0.70
MACD Signal Line 0.03
MACD Histogram -0.7341
Fundamentals Value
Market Cap 2.98 Billion
Num Shares 26.8 Million
EPS -254.14
Price-to-Earnings (P/E) Ratio -0.44
Price-to-Sales 0.00
Price-to-Book 7.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 120.40
Resistance 3 (R3) 121.05 118.57 118.84
Resistance 2 (R2) 118.57 116.19 118.25 118.32
Resistance 1 (R1) 114.81 114.72 113.57 114.17 117.80
Pivot Point 112.34 112.34 111.72 112.01 112.34
Support 1 (S1) 108.58 109.95 107.34 107.93 104.30
Support 2 (S2) 106.10 108.48 105.78 103.78
Support 3 (S3) 102.34 106.10 103.26
Support 4 (S4) 101.70